Overseas weight loss drug leader Novo Nordisk is expected to increase its annual operating profit by 40% to 46% at a constant exchange rate
Katlyn30590
发表于 2023-10-13 22:11:00
1298
0
0
Overseas weight loss drug leader Novo Nordisk is expected to increase its annual operating profit by 40% to 46% at a constant exchange rate.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- American pharmaceutical company Anjin's weight loss pills have attracted attention, and Novo Nordisk's stock price has fallen by 5%
- Earning too much! US Senators indirectly pressure Novo Nordisk to lower the price of weight loss pills
- "Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
- Oral "weight loss medication" further advances Novo Nordisk oral semaglutide weight loss phase III research success
- Lilly weight loss pills are crazily chasing after semaglutide
- The US dollar is entering a period of strength! Goldman Sachs changes its bearish view in the past two years: Trump tariffs will boost exchange rates
- Top 20 US stock transactions: Eli Lilly rises over 4%, Biden administration plans to include weight loss drugs in healthcare and subsidy programs
- After more than two years, there is finally no shortage of Zepbound, a weight loss medication from Eli Lilly
- Exchange rates plummet, Japan and South Korea urgently intervene to 'rescue the market'! A major storm has swept through the global exchange rate market
- Lilly weight loss pills are now available for purchase on e-commerce platforms. Lilly China responds that they are self funded drugs
